Regeneron Pharmaceuticals REGN Balance Sheet

Income Statement

Quarter End	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023
	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)
Total Assets	26.35B	27.21B	27.68B	29.21B	30.06B	30.66B	32.16B	33.08B
Total Current Assets	14.31B	15.53B	15.43B	15.88B	16.91B	16.92B	18.63B	19.48B
Cash and Equivalents	3.35B	3.4B	3.49B	3.11B	3.92B	1.94B	2.15B	2.73B
Total Non-Current Assets	12.04B	11.68B	12.25B	17.09B	13.15B	13.73B	13.53B	17.75B
Total Liabilities	6.43B	6.52B	6.24B	6.55B	6.56B	6.64B	7.26B	7.11B
Total Current Liabilities	3.01B	3.03B	2.88B	3.14B	3.1B	3.1B	3.6B	3.42B
Total Non-Current Liabilities	6.13B	6.18B	6.06B	6.11B	6.17B	6.24B	6.36B	6.39B
Common Equity	100k	100k	100k	100k	100k	100k	100k	100k
Retained Earnings	19.94B	20.79B	22.11B	23.31B	24.12B	25.09B	26.1B	27.26B

Year End December 30 2023	2016	2017	2018	2019	2020	2021	2022	2023
	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)
Total Assets	6.97B	8.76B	11.73B	14.81B	17.16B	25.43B	29.21B	33.08B
Total Current Assets	3.18B	4.34B	6.45B	7.69B	9.78B	14.01B	15.88B	19.48B
Cash and Equivalents	535.2M	812.73M	1.47B	1.62B	2.19B	2.89B	3.11B	2.73B
Total Non-Current Assets	4.45B	6.14B	8.76B	11.09B	11.03B	18.77B	22.66B	25.97B
Total Liabilities	2.52B	2.62B	2.98B	3.72B	6.14B	6.67B	6.55B	7.11B
Total Current Liabilities	1.24B	1.14B	1.44B	2.1B	2.7B	3.93B	3.14B	3.42B
Total Non-Current Liabilities	1.63B	2.19B	2.24B	2.33B	6.14B	4.71B	6.11B	6.39B
Total Equity	4.45B	6.14B	8.76B	11.09B	11.03B	18.77B	22.66B	25.97B
Common Equity	110k	112k	100k	100k	100k	100k	100k	100k
Retained Earnings	1.75B	2.95B	5.25B	7.38B	10.89B	18.97B	23.31B	27.26B